MCM
IONS icon

Marsico Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Marsico Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-131,190
Closed -$5.3M – 93
2015
Q3 		$5.3M Buy
+131,190
New +$6.79M 0.06% 82
2014
Q2 		– Sell
-176,633
Closed -$7.63M – 97
2014
Q1 		$7.63M Buy
+176,633
New +$8.56M 0.06% 95

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Marsico Capital Management's IONS Position: Q4 2015 in Review

Marsico Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2015, closing a stake of 131,190 shares — an estimated $5.3M sold.

Marsico Capital Management first reported a position in IONS in Q1 2014 and held it in 2 quarters. The position peaked at $7.63M in Q1 2014. 334 funds tracked by Wall St. Rank hold IONS as of Q4 2015.

  • Marsico Capital Management reported no remaining Ionis Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Marsico Capital Management sold 131,190 Ionis Pharmaceuticals shares in Q4 2015, an estimated $5.3M.
  • Marsico Capital Management first reported a position in Ionis Pharmaceuticals in Q1 2014 and held it in 2 quarters.
  • Marsico Capital Management's Ionis Pharmaceuticals position peaked at $7.63M in Q1 2014.
  • 334 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2015.

Based on Marsico Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.